Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis - COBRA study.
Andrea Ines CipleaAnna KurzejaSandra ThielSabrina HabenJessica AlexanderEvelyn AdamusKerstin HellwigPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Maternal intake of GA during breastfeeding did not adversely affect offspring safety outcomes assessed during the first 18 months of life.